GINA 2019: a fundamental change in asthma management

Abstract

<b>GINA no longer recommends treating adults/adolescents with asthma with short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.</b>http://bit.ly/310LLzE